Immune response to SARS-CoV-2 mRNA vaccine in patients with psoriasis treated with biologicsArticle Published on 2022-11-012022-11-15 Journal: Clinical and experimental dermatology [Category] [DOI] 10.1111/ced.15347 PMC 바로가기
Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective studyArticle Published on 2022-10-202022-11-15 Journal: BMC Infectious Diseases [Category] [DOI] 10.1186/s12879-022-07774-9 PMC 바로가기
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19Article Published on 2022-10-192022-11-15 Journal: PLoS Medicine [Category] [DOI] 10.1371/journal.pmed.1004120 PMC 바로가기
Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseasesArticle Published on 2022-10-132022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.1016927 PMC 바로가기
Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritisArticle Published on 2022-10-012022-11-15 Journal: RMD Open [Category] [DOI] 10.1136/rmdopen-2022-002632 PMC 바로가기
Nirmatrelvir-remdesivir association for non-hospitalized adults with COVID-19, point of viewArticle Published on 2022-10-012022-11-15 Journal: Inflammopharmacology [Category] [DOI] 10.1007/s10787-022-01055-2 PMC 바로가기
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UKArticle Published on 2022-09-292022-11-15 Journal: Clinical and experimental immunology [Category] [DOI] 10.1093/cei/uxac008 PMC 바로가기
COVID-19 and diabetic ketoacidosis: A case series at an urban district hospital in South AfricaArticle Published on 2022-09-222022-11-16 Journal: South African Family Practice [Category] [DOI] 10.4102/safp.v64i1.5590 PMC 바로가기
A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and TreatmentArticle Published on 2022-09-092022-11-15 Journal: Viruses [Category] [DOI] 10.3390/v14091999 PMC 바로가기
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccinationArticle Published on 2022-09-012022-11-15 Journal: RMD Open [Category] [DOI] 10.1136/rmdopen-2022-002293 PMC 바로가기